InFat™ based infant formula

OTHER3 trials

Sponsors

Enzymotec

Conditions

Disorder of Growth and DevelopmentHealth BehaviorPersonal Satisfaction

Unknown Phase

The Effects of Dietary Palmitic Acid Triacylglyceride Position on Bone Strength Parameters in Infants

CompletedNCT00874068

EnzymotecPersonal Satisfaction

Start: 2009-02-28End: 2010-12-31Updated: 2011-02-24

The Effects of Dietary Palmitic Acid Triacylglyceride Position on Intestinal Parameters in Infants (InFat_005)

CompletedNCT01116115

EnzymotecDisorder of Growth and Development, Health Behavior

Start: 2010-04-30End: 2010-12-31Updated: 2011-05-17

Effect of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Infants in China

CompletedNCT01373541

EnzymotecHealth Behavior, Personal Satisfaction

Start: 2011-05-31End: 2013-05-31Updated: 2014-02-13

Related Papers

Reduced crying in term infants fed high beta-palmitate formula: a double-blind randomized clinical trial.

2014-06-1931 citations